EYEPOINT PHARMACEUTICALS INC (EYPT)
US30233G2093 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -78.92M | -70.80M | -102.25M | -58.42M | -45.39M | |||
| Depreciation Amortization | 657.00K | 464.00K | 2.45M | 2.77M | 2.65M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 43.23M | 58.97M | -3.02M | -1.74M | 20.14M | |||
| Interest Paid | 665.00K | 1.41M | 2.60M | 4.85M | 5.51M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 22.55M | 13.24M | 37.83M | 7.29M | 8.17M | |||
| OPERATING CASH FLOW | -12.46M | 1.88M | -65.01M | -50.10M | -14.44M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.20M | -3.48M | -2.15M | -160.00K | -360.00K | |||
| Other Investing Activity | -10.40M | 168.00K | -15.12M | -32.97M | N/A | |||
| INVESTING CASH FLOW | -14.60M | -3.31M | -17.27M | -33.12M | -360.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -35.31M | -40.51M | 2.10M | -150.00K | -11.80M | |||
| Stock Issued/Repurchased | 233.86M | 229.55M | 400.00K | 217.20M | 50.21M | |||
| Other Financing Activity | -6.25M | -1.97M | -3.19M | -150.00K | -920.00K | |||
| FINANCING CASH FLOW | 192.31M | 187.07M | -690.00K | 216.90M | 37.49M | |||
| Exchange Rate Effect | N/A | N/A | N/A | 0.00 | N/A | |||
| CHANGE IN CASH | 165.25M | 185.63M | -82.97M | 133.68M | 22.69M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.46M | 1.88M | -65.01M | -50.10M | -14.44M | |||
| Capital Expenditure | -4.20M | -3.48M | -2.15M | -160.00K | -360.00K | |||
| FREE CASH FLOW | -16.65M | -1.61M | -67.16M | -50.26M | -14.80M | |||
All data in USD